ArticleCells2024

Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21.

Shoji Ikebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.